Skip to content
Business Company News, Finance Investment

Radium Capital unleashes $400m war chest for Aussie innovators

Radium Capital 4 mins read

Radium Capital, Australia’s leader in R&D finance, has announced plans to lend $400 million to Australian innovators over the next 12 months. 

Radium Capital has deployed more than $900 million to companies undertaking research and development (R&D) over the last eight years via Radium Advances, which allow companies to access their R&D Tax Incentive (R&DTI) refunds early.

Managing Director Jeremy Loftus said he was proud of the role Radium Capital had played in enabling Australian innovators to get their world-changing ideas to market.

We’ve been working tirelessly for years to support Australian innovators with non-dilutive capital and are immensely proud of the critical, pioneering impact we’ve had on Australian R&D,” Mr Loftus said.

“With $400 million available to deploy over the next 12 months, we have the opportunity to deliver significant impact for Australian innovators. We are excited about the number of companies we have the unique capability to support, from small startups with a great idea to established ASX-listed companies with large R&D functions.”

Radium’s non-dilutive financial solutions have helped more than 1,000 Australian businesses unlock their expected R&DTI refund early to accelerate commercialisation, reduce capital outlay, smooth year-round cash flow, and attract other funding sources. 

Since its founding, Radium has led the growth of R&D funding in Australia, and Mr Loftus said it was positive to see the growing awareness of R&D finance and the vital role it played in the innovation funding landscape.

We’ve seen a huge uptick in interest over the last three years as R&D lending has become more mainstream. When Radium came onto the market in 2017, it took us over six months to write our first $10 million in loans. Now, we do that amount roughly every couple of weeks.

“More and more businesses are realising they can leverage Radium’s financing solutions to strategically boost their R&D budget, delay a capital raise, improve their offering to investors, or provide cash when they need it the most, without having to wait up to 18 months for their R&DTI refund or diluting their equity in the business,” he said.

Radium has been an important part of the success of a growing list of companies, such as WeMoney, helping people manage their finances; Rapid Response Revival, the maker of CellAED®, the world’s first ultraportable personal defibrillator; and ElectraLith, sustainably extracting and producing battery-grade lithium, to name only a few.

We are proud to enable research and development that has the potential to change lives across Australia and the world, while also creating jobs, building sovereign capability and strengthening the Australian economy,” Mr Loftus said.

ENDS

 

Media Contact

Sally Dillon
Communications and Content Manager
0425 751 900
[email protected]

 

Featured Case Studies (based in Sydney, Perth & Melbourne)

Rapid Response Revival – This Sydney-based company is saving lives around the world with its CellAED® portable defibrillator, created to increase survival rates for people suffering a heart attack. Every minute counts between the onset of a heart attack and emergency services arrival, and founder and CEO Donovan Casey created CellAED to make portable defibrillation more affordable, accessible and effective for use by bystanders. CellAED is the world’s first personal AED and represents the first real improvements on AED technology in more than 30 years.

“Accessing multiple Radium Advances strategically and reinvesting them in R&D was a game changer that continues to help us commercialise our innovation and grow,” said Damian Shrubsole, CellAED Company Secretary and Head of Investor Relations. “The Radium team is highly client-focused, and Radium Advance is an excellent non-dilutive funding option that’s fast and easy to access for start-ups and scale-ups like ours.”

Read the Rapid Response Revival Case Study

WeMoney – This Perth-based financial wellness platform empowers people to take control of their finances and pay off debt faster by comparing products and providing insights into user spending. Launched in 2020, WeMoney recently secured $12 million in a Series A round at a $100 million valuation.

“Radium Advances allowed us to fast-forward our R&D programs, complete product development and platform improvements months ahead of schedule and score a home run for our members and investors,” said Dan Jovevski, WeMoney Founder and CEO. “I can’t say enough good things about the exceptional Radium platform technology, financing and all-round service of the Radium team.”

Read the WeMoney Case Study

ElectraLith – Sustainable mining tech company ElectraLith has developed the next generation of lithium extraction and refining technology. The company recently won the World Economic Forum’s prestigious “Sustainable Mining: Mining the Unmined Challenge Award” for its low-cost, sustainable technology that refines battery-grade lithium without using water or chemicals. This Monash University spinout is commercialising at pace, reinvesting its Radium Advance in R&D before closing its materially oversubscribed $27.5 million Series A funding round in January this year. Led by deep tech investment fund Main Sequence, ElectraLith’s world-class investor syndicate is comprised of IP Group, Hostplus, Rio Tinto, Chevron Technology Ventures, Fathom Fund, Breakthrough Victoria, Vista Energy, Marathon Petroleum, In-Q-Tel and Monash University. 

“Radium Advance is an excellent non-dilutive funding option that’s fast and easy to access for start-ups and scale-ups,” said ElectraLith CEO Charlie McGill. “A long-established and trusted R&D lender, Radium Capital provided the perfect bridge capital solution for our business.”

Read the ElectraLith Case Study

 

 


About us:

About Radium

Radium Capital powers Australian innovators by partnering to provide access to the funding, resources, and connections they need to move from ideas to impact. Through Radium Advances, businesses can unlock their R&DTI refund early to accelerate commercialisation, reduce capital outlay and attract other funding sources. Radium Capital operates nationally, with offices in Sydney, Melbourne, Brisbane and Perth, and aims to support businesses of all sizes to grow. Learn more at www.RadiumCapital.com.au.

Media

More from this category

  • Finance Investment, Government Federal
  • 08/07/2025
  • 15:32
ACOSS

RBA misses opportunity to provide relief

ACOSS is deeply disappointed by today’s decision by the Reserve Bank of Australia to leave interest rates on hold, saying there is a missed crucial opportunity to deliver relief to millions of people doing it tough. “Today’s decision is a blow for millions of people in Australia on low and modest incomes who are struggling to cover the basics,” ACOSS Acting CEO Jacqueline Phillips said. “It means that it will take longer to restore growth in jobs and wages after a decade of stagnation. “With inflation now well within the target range, there is no justification for keeping rates at…

  • Business Company News
  • 08/07/2025
  • 15:28
CPA Australia

RBA interest rates decision adds pressure to government’s productivity roundtable

8 July 2025 RBA interest rates decision adds pressure to government’s productivity roundtable SMEs continue to navigate uncertain economic waters Government’s focus on productivity…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 08/07/2025
  • 11:08
Nova Eye Medical (ASX:EYE)

Nova Eye Medical Delivers Record Revenues for FY25

HIGHLIGHTS Record revenues of A$28.8m for the year ended 30 June 2025 and in line with guidance Six consecutive half-years of growth in the USA with H2FY25 US sales up 25% onpcp Q4FY25 sales of A$8.4m the highest on record Nova Eye Medical Limited (ASX: EYE) (Nova Eye or the Company) is pleased to report a record sales result for FY25. Group revenue for FY25 reached A$28.8 million (US$18.4 million), up 21% (in constant currency) from FY24. Key drivers include: US sales of US$14.2 million, up 25% withiTrack™ Advance delivering six consecutive half-years of revenue growth. H2FY25 sales A$15.7 million…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.